George Soros Biomarin Pharmaceutical Inc Transaction History
Soros Fund Management LLC
- $4.01 Billion
- Q1 2024
A detailed history of George Soros (Soros Fund Management LLC) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Soros Fund Management LLC holds 155,900 shares of BMRN stock, worth $13.2 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
155,900Holding current value
$13.2 Million% of portfolio
0.34%Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
621Shares Held
182MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.58 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.53 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.22 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.18 Billion0.75% of portfolio
-
State Street Corp Boston, MA6.9MShares$583 Million0.03% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.7B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...